Información de la revista
Vol. 29. Núm. 1.Febrero 2009
Páginas 1-94
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. 1.Febrero 2009
Páginas 1-94
DOI: 10.3265/Nefrologia.2009.29.1.81.1.en.full.pdf
Acceso a texto completo
Comment on: IgA nephropathy and lupus antiacoagulant: an incidental association?
Comment on: IgA nephropathy and lupus antiacoagulant: an incidental association?
Visitas
...
Jae Il Shina, Jae Seung Leea
a Department of Pediatrics, The Institute of Kidney Disease, Yonsei University College of Medicine, Severance Children¿s Hospital, Seoul, Seoul, Korea,
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Dear Editor,

We read with interest the article by Heras et al.1 They reported the occurrence of IgA nephropathy (IgAN) in two sisters, one of whom had lupus anticoagulant (LA) and wondered whether this association was incidental or related to a common immune pathogenetic mechanism.1

Although not extensively studied in IgAN, there have been some reports on the associations of antiphospholipid antibodies with Henoch-Schönlein purpura (HSP),2, 3 which has a common pathogenesis of IgAN. Also, Kawakami et al.4 recently reported a relatively high prevalence of antiphospholipid antibodies in adults with HSP. In their report, 4 22 (73%) of the 30 HSP patients were positive for serum IgA anticardiolipin antibodies, 19 (63%) had IgA anti-phosphatidylserine-prothrombin complex (anti-PS/PT) antibodies and 20 (67%) IgM anti-PS/PT antibodies, suggesting that the prevalence of antiphospholipid antibodies have been underestimated in patients with HSP in the past, although thrombotic episodes were not evident in their patients.4 They also showed that serum IgA anticardiolipin antibody levels were also significantly associated with proteinuria (a marker of nephritis severity).4 Considering the similarity of renal histopathology between IgAN and HSP nephritis, antiphospholipid antibodies may have a pathogenic role in the development of IgA-mediated glomerulonephritis.

Furthermore, because some authors showed that antiphospholipid antibodies could cause thrombosis in patients with HSP,2, 3 and it was reported that anticardiolipin antibodies of IgG, IgM and IgA isotypes from patients with the antiphospholipid syndrome could play a role in thrombosis in vivo,5 careful clinical monitoring for thrombosis would be necessary in patients with HSP or IgAN who show positive antiphospholipid antibodies.

Therefore, further studies should be performed to evaluate the prevalence and pathogenic role of antiphospholipid antibodies in patients with IgAN and the relationships among antiphospholipid antibodies, the severity of IgAN, and thrombosis should be further elucidated in the future.

Bibliografía
[1]
Heras MB, Fisac RH, Fernández-Reyes MJ, Sánchez RH. IgA nephropathy and lupus antiacoagulant: an incidental association? Nefrologia 2008; 28 (4): 466-467. [Pubmed]
[2]
Abend NS, Licht DJ, Spencer CH. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura. Pediatr Neurol 2007; 36 (5): 345-347. [Pubmed]
[3]
Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura. Arch Dis Child 2002; 86 (2): 132-133. [Pubmed]
[4]
Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum 2008; 59 (4): 561-567. [Pubmed]
[5]
Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74 (5): 1361-1367. [Pubmed]
Idiomas
Nefrología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.